NOVABAY PHARMACEUTICALS, INC.

Profile

Company Names

NOVABAY PHARMACEUTICALS, INC.

Addresses

2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA 94608

2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA 94608

2000 POWELL STREET, SUITE 1500, EMERYVILLE, CA 94608

5980 HORTON STREET, SUITE 550, EMERYVILLE, CA 94608

5980 HORTON STREET, SUITE 550, EMERYVILLE, CA 94608

Phone Numbers

(510) 899-8800

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$205,299,532.00

Number of Funding Rounds:

15
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
15
2026-01-16 
$134,000,000.00 
$134,000,000.00 
$0.00 
 
14
2024-06-14 
$225,953.00 
$225,953.00 
$0.00 
 
13
2024-03-24 
$665,000.00 
$665,000.00 
$0.00 
Debt 
12
2023-12-21 
$554,808.00 
$554,808.00 
$0.00 
 
11
2023-05-01 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
10
2022-09-09 
$2,065,500.00 
$2,065,500.00 
$0.00 
Equity 
9
2021-11-02 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
8
2020-07-20 
$0.00 
$6,829,580.00 
$6,829,580.00 
 
7
2020-05-13 
$1,030.00 
$1,731,030.00 
$1,730,000.00 
Equity 
6
2019-08-13 
$4,198,566.00 
$4,198,566.00 
$0.00 
 
5
2019-06-26 
$2,400,000.00 
$2,400,000.00 
$0.00 
Equity 
4
2018-02-05 
$5,984,000.00 
$5,984,000.00 
$0.00 
Equity 
3
2016-05-09 
$7,791,000.00 
$11,791,000.00 
$4,000,000.00 
Equity 
2
2016-02-16 
$2,830,804.00 
$2,830,804.00 
$0.00 
Equity 
1
2015-03-06 
$26,582,871.00 
$26,582,871.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
 
CASHION 
DIRECTOR
PAUL 
 
FREIMAN 
DIRECTOR
PAUL 
E. 
FREIMAN 
DIRECTOR
JULIE 
 
GARLIKOV 
DIRECTOR
JUSTIN 
 
HALL 
EXECUTIVE OFFICER, DIRECTOR
JUSTIN 
M. 
HALL 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
JOHN 
KAZLEY 
EXECUTIVE OFFICER, DIRECTOR
AUDREY 
 
KUNIN 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
 
KUNIN 
EXECUTIVE OFFICER
TOMMY 
 
LAW 
EXECUTIVE OFFICER
XINZHOU (PAUL) 
 
LI 
DIRECTOR
XIAOYAN 
 
LIU 
DIRECTOR
XIAOYAN (HENRY) 
 
LIU 
DIRECTOR
YONGHAO (CARL) 
 
MA 
DIRECTOR
GAIL 
J. 
MADERIS 
DIRECTOR
JOHN 
J. 
MCGOVERN 
EXECUTIVE OFFICER
T. 
ALEX 
MCPHERSON 
DIRECTOR
T. ALEX 
 
MCPHERSON 
DIRECTOR
RAMIN (RON) 
 
NAJAFI 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
PAULSON 
EXECUTIVE OFFICER
THOMAS 
J. 
PAULSON 
EXECUTIVE OFFICER
MASSIMO 
 
RADAELLI 
DIRECTOR
JASON 
 
RALEIGH 
EXECUTIVE OFFICER
MARK 
 
SIECZKAREK 
DIRECTOR
MARK 
M. 
SIECZKAREK 
EXECUTIVE OFFICER, DIRECTOR
SWAN 
 
SIT 
DIRECTOR
LEWIS 
J. 
STUART 
EXECUTIVE OFFICER
XIAOPEI (RAY) 
 
WANG 
DIRECTOR
TONY 
 
WICKS 
DIRECTOR
MIJIA 
 
WU 
DIRECTOR
MIJIA (BOB) 
 
WU 
DIRECTOR
ROY 
J. 
WU 
EXECUTIVE OFFICER
TODD 
 
ZAVODNICK 
DIRECTOR
YENYOU (JEFF) 
 
ZHENG 
DIRECTOR
YONGXIANG (SEAN) 
 
ZHENG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-01-16 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-06-14 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-03-24 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-12-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-05-01 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-09-09 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-02 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-07-20 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-13 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-08-13 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-13 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-06-26 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-02-05 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-05-09 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-02-16 
D/A
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-06 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
LADENBURG THALMANN + CO, INC.
505
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
N/A
NONE
MAXIM GROUP LLC
NONE